![](https://monteverdelaw.com/wp-content/uploads/case-logo/vectivbio-holding-ag.png)
VectivBio Holding AG (NASDAQ: VECT), relating to its proposed sale to Ironwood Pharmaceuticals Inc. Under the terms of the tender offer, VECT shareholders are expected to receive $17.00 in cash per share they own.
VectivBio Holding AG (NASDAQ: VECT), relating to its proposed sale to Ironwood Pharmaceuticals Inc. Under the terms of the tender offer, VECT shareholders are expected to receive $17.00 in cash per share they own.